Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc C Chamberlain

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
Neuro-Oncology|July 10, 2010
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastomaMyrna R Rosenfeld, Marc C Chamberlain, Stuart A Grossman, et al.
Cancer|July 29, 2010
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomasJeffrey J Raizer, Sean Grimm, Marc C Chamberlain, et al.
BBA Clinical|January 6, 2015
O<sup>6</sup>-methylguanine-DNA methyltransferase activity is associated with response to alkylating agent therapy and with <i>MGMT</i> promoter methylation in glioblastoma and anaplastic gliomaMichael S Bobola, Mohammad Alnoor, John Y-S Chen, et al.
Anti-Cancer Drugs|August 22, 2013
Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case seriesEmilie Le Rhun, Sophie Taillibert, Patrick Devos, et al.
Journal of Neuro-Oncology|January 29, 2014
CSF CA 15-3 in breast cancer-related leptomeningeal metastasesEmilie Le Rhun, Andrew Kramar, Sophie Salingue, et al.
Blood|April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportSigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Journal of Neuro-Oncology|December 24, 2014
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter studyManmeet S Ahluwalia, Hao Xie, Saurabh Dahiya, et al.
Neuro-Oncology|April 24, 2016
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomasNathalie L Albert, Michael Weller, Bogdana Suchorska, et al.
Neuro-Oncology Advances|October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningiomaPriya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastomaWolfgang Wick, Vinay K Puduvalli, Marc C Chamberlain, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
Neuro-Oncology|July 10, 2010
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastomaMyrna R Rosenfeld, Marc C Chamberlain, Stuart A Grossman, et al.
Cancer|July 29, 2010
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomasJeffrey J Raizer, Sean Grimm, Marc C Chamberlain, et al.
BBA Clinical|January 6, 2015
O<sup>6</sup>-methylguanine-DNA methyltransferase activity is associated with response to alkylating agent therapy and with <i>MGMT</i> promoter methylation in glioblastoma and anaplastic gliomaMichael S Bobola, Mohammad Alnoor, John Y-S Chen, et al.
Anti-Cancer Drugs|August 22, 2013
Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case seriesEmilie Le Rhun, Sophie Taillibert, Patrick Devos, et al.
Journal of Neuro-Oncology|January 29, 2014
CSF CA 15-3 in breast cancer-related leptomeningeal metastasesEmilie Le Rhun, Andrew Kramar, Sophie Salingue, et al.
Blood|April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportSigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Journal of Neuro-Oncology|December 24, 2014
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter studyManmeet S Ahluwalia, Hao Xie, Saurabh Dahiya, et al.
Neuro-Oncology|April 24, 2016
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomasNathalie L Albert, Michael Weller, Bogdana Suchorska, et al.
Neuro-Oncology Advances|October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningiomaPriya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastomaWolfgang Wick, Vinay K Puduvalli, Marc C Chamberlain, et al.
Pageof 25